Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1152 of 5804
-
Cold water trick may stop pancreatitis after common procedure
Prevention Recruiting nowThis study is designed to learn whether rinsing the papilla with cold water at the end of an ERCP procedure, in addition to standard medicine, can help lower the chance of developing pancreatitis, which is the most common major complication after ERCP.
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:30 UTC
-
New nasal spray aims to stop colds and flu before they start
Prevention Recruiting nowAcute upper and lower respiratory infections are a major public health problem and a leading cause of morbidity and mortality worldwide. The purpose of this trial is to assess the safety of the investigational agent INNA-051, given intranasally, and its potential effectiveness in…
Phase: PHASE2 • Sponsor: ENA Respiratory Pty Ltd • Aim: Prevention
Last updated Jun 27, 2026 09:05 UTC
-
Ultrasound study to see if guselkumab eases psoriatic arthritis
Disease control Recruiting nowThe purpose of this study is to assess how well guselkumab works in improving symptoms of psoriatic arthritis (an inflammatory disease that affects the joints in participants with psoriasis, a skin condition that causes red, scaly patches) using muscoloskeletal ultrasound (MSUS) …
Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Immune booster drug tested on rare cancers
Disease control Recruiting nowThe purpose of the study is to find out if pembrolizumab is a useful treatment that causes few or mild side effects in people with ultra-rare sarcoma. The researchers will also study how the immune system responds to the study treatment. Pembrolizumab is a type of drug called a …
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could a sleep pill curb alcohol cravings? new trial investigates
Disease control Recruiting nowThe goal of this clinical trial is to learn if, how, and for whom suvorexant (SUV) works to treat alcohol use disorder (AUD). The main questions it aims to answer are: * Is SUV effective for AUD? * Does SUV dampen stress reactivity? * Can the researchers develop a biomarker for …
Phase: PHASE2 • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can a cancer drug combo fight frailty in HIV?
Disease control OngoingThis clinical trial is a Phase II study designed to test the safety and effectiveness of a combination of dasatinib and quercetin (D+Q) in improving physical function for people with HIV who are frail or prefrail. The study will involve 80 participants, all aged 50 or older, who …
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
AI takes on ear infections: could cut unnecessary antibiotics in kids
Diagnosis Recruiting nowEar infections are common in young children with cold symptoms, but they can be difficult to diagnose due to small ear canals, child movement, and limited viewing time. In this study, investigators will take photos of the eardrums of children 6-24 months of age with upper respira…
Phase: NA • Sponsor: Timothy Shope • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
Gene therapy targets chronic nerve pain in new trial
Disease control Recruiting nowThis research is being done to study a possible treatment for refractory pain due to small fiber neuropathy (SFN). ST-503 is intended to deliver a modified copy of the gene which will ideally repress Nav1.7 tissue-related pain signals reaching the brain, which should reduce the …
Phase: PHASE1, PHASE2 • Sponsor: Sangamo Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can High-Tech eye exams save sight in underserved communities?
Diagnosis Recruiting nowTo compare eye disease detection rates at a Federally Qualified Health Center between a technology-enhanced protocol and standard optometric clinical examination for three of the leading causes of blindness: glaucoma, diabetic retinopathy, and visually significant cataract.
Phase: NA • Sponsor: University of Michigan • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
New RSV vaccine study aims to protect vulnerable patients
⭐️ VACCINE ⭐️ Recruiting nowThis clinical trial is being done to learn more about how well a vaccine (Arexvy®) for respiratory syncytial virus, also known as RSV, works in people with weakened immune systems. The main questions it aims to answer are: * Does 1 or 2 doses of Arexvy work better in people with…
Phase: PHASE2 • Sponsor: Johns Hopkins University • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:03 UTC
-
AI spots silent liver danger in ER scans
Diagnosis ENROLLING_BY_INVITATIONHepatic steatosis is a common radiographic "incidental finding" that is overlooked and underreported to patients. The investigators developed a clinical decision support system using machine learning and natural language processing that will prompt reporting to patients and provi…
Phase: NA • Sponsor: Northwestern University • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Step toward prevention: app-based exercise may protect the brain in Parkinson's risk group
Prevention Recruiting nowα-Synucleinopathies, including Parkinson's disease and dementia with Lewy bodies, are the second most common neurodegenerative diseases. In addition to progressive motor deterioration, cognitive decline is a key element of the non-motor symptom complex of these diseases. Isolated…
Phase: NA • Sponsor: University Hospital, Bonn • Aim: Prevention
Last updated Jun 27, 2026 08:11 UTC
-
New MRI scan could spare kidney transplant patients painful biopsies
Diagnosis Recruiting nowThis clinical study aims to investigate a new, non-invasive method for monitoring kidney function after transplantation. Currently, assessing the health of a transplanted kidney often relies on blood tests or invasive biopsies, which may not detect subtle early changes or account…
Sponsor: Tongji Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
New hope for FSGS: experimental drug enters Mid-Stage trial
Disease control Recruiting nowThis is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study designed to evaluate the efficacy and safety of praliciguat in adults with biopsy-confirmed focal segmental glomerulosclerosis (FSGS). Participants will be randomized 1:1 to receive praliciguat or …
Phase: PHASE2 • Sponsor: Akebia Therapeutics • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New pill VENT-03 aims to calm lupus skin flares
Disease control Recruiting nowThe goal of this clinical trial is to learn if VENT-03 works to treat patients with cutaneous lupus erythematosus (CLE) who may or may not have systemic lupus erythematosus (SLE). Another goal is to learn about the safety of VENT-03 and how it is processed by the body. The main q…
Phase: PHASE2 • Sponsor: Ventus Therapeutics U.S., Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New drug cocktail aims to tame transplant complication
Disease control Recruiting nowThis study aims to evaluate the optimal dose (Recommended Phase 2 Dose, RP2D), preliminary safety, and efficacy of gecacitinib (also known as jaktinib) in combination with glucocorticoids as first-line therapy for patients with grade II-IV acute graft-versus-host disease (aGVHD) …
Phase: PHASE1, PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New smart drug targets cancer cells while sparing healthy ones
Disease control Recruiting nowThe goal of this clinical trial is to test a new medicine called GSK5764227, which delivers a toxin directly to cancer cells to destroy them while sparing healthy cells. The study will combine GSK5764227 with standard treatments to evaluate its safety, examine how the body proces…
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New drug cocktail aims to shrink tough cancers
Disease control Recruiting nowThis is a Phase Ib/II clinical study. The Phase Ib dose-escalation study aims to evaluate and determine the recommended Phase II dose (RP2D) of TCC1727 in combination with benmelstobart /olaparib /topotecanfor patients with advanced solid tumors. The Phase II expansion study wil…
Phase: PHASE1, PHASE2 • Sponsor: Beijing Tide Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Red light therapy for IVF embryos: a new hope for fertility?
Disease control OngoingEmbryos need a lot of energy to grow, but as women get older, the "power plants" of the cells (called mitochondria) don't work as well. This makes it harder for embryos to develop normally. One possible way to help is with a gentle light treatment called photobiomodulation (PBM).…
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a magnet zap your way to better walking after a stroke?
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, feasibility, and efficacy of vagus nerve stimulation (VNS) paired with mobility training to improve lower extremity function and gait in individuals with chronic ischemic stroke.
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC